News

Article

Jyoti D. Patel on the Progress of Immunotherapy in NSCLC

Author(s):

Key Takeaways

  • Immunotherapy is showing promise as a treatment for non-small cell lung cancer (NSCLC), with significant advancements reported at the 2015 ASCO meeting.
  • Jyoti D. Patel highlighted the progress in immunotherapy for NSCLC, emphasizing its potential to improve patient outcomes.
SHOW MORE

Jyoti D. Patel, ASCO expert, associate professor, Northwestern University Feinberg School of Medicine, discusses the progress of immunotherapy as treatment for patients with non-small cell lung cancer.

Jyoti D. Patel, ASCO expert, associate professor, Northwestern University Feinberg School of Medicine, discusses the progress of immunotherapy as treatment for patients with non-small cell lung cancer (NSCLC). Patel is reporting on data presented at the 2015 annual meeting of the American Society of Clinical Oncology, a gathering of nearly 30,000 oncology professionals in Chicago.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Photo of Dr. Rosario Ligresti
Image of women with text.
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.